Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Experts debate wisdom of delaying second COVID-19 vaccine dose
Another proposed strategy to extend the current supply of COVID-19 vaccines to more Americans involves...
News
After COVID-19 infection, antibodies highly protective for months, prospective study shows
“It’s great news because there have been so many questions regarding whether or not you can be protected against reinfection, and this health care...
News
FDA grants emergency use for Moderna COVID-19 vaccine
“It’s incumbent upon all us healthcare professionals to put ourselves out there as supporting this vaccine and supporting people getting it.”
News
Vaccine rollout on track, expect 300 million doses through March: Feds
Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the U.S. by March 31.
News
FDA OKs emergency use of Pfizer COVID-19 vaccine
“Vaccinating healthcare workers, in particular, will be a model for the general public.”
News
Biden chooses California Attorney General Xavier Becerra to head HHS
Although his public health experience is limited, he served on the Congressional Ways and Means Committee overseeing health-related issues.
News
CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions
The residual risk is approximately 1%, with an upper limit of 10%, when people quarantine for 10 days. .
News
Moderna filing for FDA emergency COVID-19 vaccine approval, reports 94.1% efficacy
Vaccine efficacy remained consistent across different groups analyzed by age, race/ethnicity, and gender.
News
IDSA updates COVID guidelines for antibodies, antivirals, other drugs
Panel cautions against routine use of bamlanivimab and notes that remdesivir can shorten the clinical course of COVID-19.
News
Debate: After methotrexate failure, is JAK inhibitor or biologic next?
Experts pointed to differences in safety, clinical experience, and cost when considering Janus kinase inhibitors or biologic treatment after a...
News
Pfizer’s COVID-19 vaccine 95% effective in final phase 3 results
The vaccine was well tolerated with no serious safety concerns.
Article
Moderna: Interim data show 94.5% efficacy for COVID-19 vaccine, will seek FDA EUA
The first interim results of the phase 3 COVE trial included 95 participants with confirmed COVID-19.